Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Controlled Release

• Publication date

  2015-03-10

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2015.01.025PMID 25620068PMCID PMC4330128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Next generation drying technologies for pharmaceutical applications.

  2014cited by this paper
• Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.

  2014cited by this paper
• Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.

  2014cited by this paper
• Influence of polymeric microcarriers on the in vivo intranasal uptake of an anti-migraine drug for brain targeting.

  2013cited by this paper
• Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine

  2013cited by this paper
• Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.

  2013cited by this paper
• Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury

  2013cited by this paper
• High Dose Deferoxamine in Intracerebral Hemorrhage (Hi-Def) Trial: Rationale, Design, and Methods

  2013cited by this paper
• Comparison of Deferoxamine and Methylprednisolone: Protective Effect of Pharmacological Agents on Lipid Peroxidation in Spinal Cord Injury in Rats

  2013cited by this paper
• Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.

  2013cited by this paper
• Iron chelation and multiple sclerosis

  2013cited by this paper
• Intranasal delivery of growth differentiation factor 5 to the central nervous system

  2012cited by this paper
• Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study.

  2012cited by this paper
• Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice

  2012cited by this paper
• Intranasal deferoxamine improves performance in radial arm water maze, stabilizes HIF-1α, and phosphorylates GSK3β in P301L tau transgenic mice

  2012cited by this paper
• Alterations in brain transition metals in Huntington disease: an evolving and intricate story.

  2012cited by this paper
• An update on iron chelation therapy.

  2012cited by this paper
• Safety and Tolerability of Deferoxamine Mesylate in Patients With Acute Intracerebral Hemorrhage

  2011cited by this paper
• Development of solid nanoparticles based on hydroxypropyl‐β‐cyclodextrin aimed for the colonic transmucosal delivery of diclofenac sodium

  2011cited by this paper
• Influence of chitosan glutamate on the in vivo intranasal absorption of rokitamycin from microspheres.

  2011cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010influential reference
• Methyl‐beta‐cyclodextrin induces mitochondrial cholesterol depletion and alters the mitochondrial structure and bioenergetics

  2010cited by this paper
• A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.

  2009cited by this paper
• Fenton chemistry and oxidative stress mediate the toxicity of the β-amyloid peptide in a Drosophila model of Alzheimer’s disease

  2009cited by this paper
• Dysregulation of Iron Homeostasis in the CNS Contributes to Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis

  2009cited by this paper
• Abnormal Brain Iron Homeostasis in Human and Animal Prion Disorders

  2009cited by this paper
• Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

  2009influential reference
• Nanoparticles for direct nose-to-brain delivery of drugs.

  2009cited by this paper
• Computational modelling of gas-particle flows with different particle morphology in the human nasal cavity

  2009cited by this paper
• Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo

  2009cited by this paper
• Brain uptake of an anti-ischemic agent by nasal administration of microparticles.

  2008cited by this paper
• Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide.

  2008cited by this paper
• Deferoxamine therapy for intracerebral hemorrhage.

  2008cited by this paper
• Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

  2008cited by this paper
• Tandem mass spectrometry of coprogen and deferoxamine hydroxamic siderophores.

  2006cited by this paper
• Cyclodextrins in drug delivery: An updated review

  2005cited by this paper
• The role of iron neurotoxicity in ischemic stroke.

  2004cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Nasal route and drug delivery systems

  2004cited by this paper
• Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats.

  2004cited by this paper
• Chitosan microspheres as a potential carrier for drugs.

  2004cited by this paper
• Nasal drug delivery--possibilities, problems and solutions.

  2003cited by this paper
• Caffeine microparticles for nasal administration obtained by spray drying.

  2002influential reference
• In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits.

  2002cited by this paper
• Serial cerebrospinal fluid sampling in a rat model to study drug uptake from the nasal cavity.

  2002cited by this paper
• Nasal drug delivery: new developments and strategies.

  2002cited by this paper
• Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease

  2001cited by this paper
• First human studies with a high-molecular-weight iron chelator.

  2000cited by this paper
• Cyclodextrins in nasal drug delivery.

  1999cited by this paper
• The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems.

  1999cited by this paper
• Nasal delivery systems and their effect on deposition and absorption.

  1998cited by this paper
• Deferoxamine Posttreatment Reduces Ischemic Brain Injury in Neonatal Rats

  1994cited by this paper
• Pharmacokinetics of fluconazole in cerebrospinal fluid and serum of rabbits: validation of an animal model used to measure drug concentrations in cerebrospinal fluid

  1994cited by this paper
• A high-performance liquid chromatographic method for the measurement of deferoxamine in body fluids.

  1989cited by this paper
• Protein size and cerebrospinal fluid composition

  1974cited by this paper

• Neuroprotective role of thyme polyphenols-loaded β-cyclodextrin–chitosan nanocarriers against cisplatin-induced brain toxicity: In vivo studies and molecular mechanisms

  2025cites this paper
• Current insights into polymeric micelles for nasal drug delivery

  2025cites this paper
• Ferroptosis in Alzheimer's Disease: The Regulatory Role of Glial Cells.

  2025cites this paper
• Nose to brain delivery of insulin loaded in PLGA and Chitosan-Coated PLGA Nanoparticles: A Promising Approach for Alzheimer’s disease therapy

  2025cites this paper
• NANOTECHNOLOGY-DRIVEN THERAPEUTICS: ENHANCING BRAIN DRUG DELIVERY VIA NASAL PATHWAYS

  2025cites this paper
• Nasal Administration of a Nanoemulsion Based on Methyl Ferulate and Eugenol Encapsulated in Chitosan Oleate: Uptake Studies in the Central Nervous System

  2025cites this paper
• Intranasal Delivery of Dimethyl fumarate and Monomethyl fumarate Using Hyaluronic Acid-Based Hybrid Nanoparticles to Enhance CNS Bioavailability

  2025cites this paper
• Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery

  2025cites this paper
• Network pharmacology and bioinformatics analyses indicate a potential anti-aging effect of deferoxamine in mesenchymal stem cells

  2025cites this paper
• In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route

  2024cites this paper
• Bile Acid–Targeted Hyaluronic Acid Nanoparticles for Enhanced Oral Absorption of Deferoxamine

  2024cites this paper
• Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases

  2024cites this paper
• Microparticles and Multi-unit Systems for Advanced Drug Delivery.

  2024cites this paper
• Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease

  2024cites this paper
• Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous system.

  2024cites this paper
• Nose-to-brain delivery of microcarrier in the treatment of neurodegenerative diseases

  2024cites this paper
• Development and study of mucoadhesive microcapsules for the nasal levodopa delivery

  2024cites this paper
• The role of ferritinophagy and ferroptosis in Alzheimer's disease.

  2024cites this paper
• Pharmacokinetic Study of Fingolimod Nasal Films Administered via Nose-to-Brain Route in C57BL/6 J Mice as Potential Treatment for Multiple Sclerosis

  2024cites this paper
• A thermosensitive chitosan hydrogel: An attempt for the nasal delivery of dimethyl fumarate.

  2024cites this paper
• Unraveling the Ties: Type 2 Diabetes and Parkinson's Disease - A Nano-Based Targeted Drug Delivery Approach.

  2024cites this paper
• Design and development of a chitosan-based nasal powder of dimethyl fumarate-cyclodextrin binary systems aimed at nose-to-brain administration. A stability study.

  2024cites this paper
• Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles

  2023cites this paper
• Ion-activated In Situ Gel of Gellan Gum Containing Chrysin for Nasal Administration in Parkinson's Disease.

  2023cites this paper
• Screening of the action mechanisms involved in the antinociceptive effect of isopulegol and its complex in cyclodextrin using acute nociception models in mice

  2023cites this paper
• Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics

  2023cites this paper
• Nose-to-Brain delivery of antiretroviral drug loaded lipidic nanocarriers to purge HIV reservoirs in CNS: A safer approach

  2023cites this paper
• Polysaccharide-based platforms for nasal delivery: design, features, and perspectives

  2023cites this paper
• Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review.

  2023cites this paper
• Small-Molecule Ferritin Degrader as a Pyroptosis Inducer.

  2023cites this paper
• Multifunctionalized Cationic Chitosan Polymeric Micelles Polyplexed with pVGF for Noninvasive Delivery to the Mouse Brain through the Intranasal Route for Developing Therapeutics for Alzheimer's Disease.

  2023cites this paper
• Nose-to-Brain Targeting via Nanoemulsion: Significance and Evidence

  2023cites this paper
• Intranasal Lipid Nanoparticles Containing Bioactive Compounds Obtained from Marine Sources to Manage Neurodegenerative Diseases

  2023cites this paper
• Evaluation of Recent Intranasal Drug Delivery Systems to the Central Nervous System

  2022cites this paper
• Improving in vivo oral bioavailability of a poorly soluble drug: a case study on polymeric versus lipid nanoparticles

  2022cites this paper
• Study on the nasal drug delivery system of PPX microcapsules in situ thermosensitive gel.

  2022cites this paper
• Insight into the potential role of ferroptosis in neurodegenerative diseases

  2022cites this paper
• Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients

  2022cites this paper
• Development and In Vitro-Ex Vivo Evaluation of Novel Polymeric Nasal Donepezil Films for Potential Use in Alzheimer’s Disease Using Experimental Design

  2022cites this paper
• Tailoring functional spray-dried powder platform for efficient donepezil nose-to-brain delivery.

  2022cites this paper
• Polyphenols and polyphenols-based biopolymer materials: Regulating iron absorption and availability from spontaneous to controllable

  2022cites this paper
• Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders

  2022cites this paper
• Novel Utilization of Therapeutic Coatings Based on Infiltrated Encapsulated Rose Bengal Microspheres in Porous Titanium for Implant Applications

  2022cites this paper
• Peptide Tool-Driven Functional Elucidation of Biomolecules Related to Endocrine System and Metabolism.

  2022cites this paper
• Surfactant-Free Chitosan/Cellulose Acetate Phthalate Nanoparticles: An Attempt to Solve the Needs of Captopril Administration in Paediatrics

  2022cites this paper
• Effect of Different Absorption Enhancers on the Nasal Absorption of Nalmefene Hydrochloride

  2022cites this paper
• Spray dried powders for nasal delivery: Process and formulation considerations.

  2022cites this paper
• Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?

  2022cites this paper
• NOSE-TO-BRAIN DRUG DELIVERY: AN UPDATE TO THE ALTERNATIVE PATH TO SUCCESSFUL TARGETED ANTI-MIGRAINE DRUGS

  2021cites this paper
• Intranasal route: The green corridor for Alzheimer's disease therapeutics

  2021cites this paper
• Particulate carriers for nose-to-brain delivery

  2021cites this paper
• Applications of direct nose-to-brain drug delivery in medicine and pharmacy

  2021cites this paper
• Targeting Systems to the Brain Obtained by Merging Prodrugs, Nanoparticles, and Nasal Administration

  2021cites this paper
• Efficient Iron and ROS Nanoscavengers for Brain Protection after Intracerebral Hemorrhage.

  2021cites this paper
• Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

  2021influential citation
• Nasal powders of quercetin-β-cyclodextrin derivatives complexes with mannitol/lecithin microparticles for Nose-to-Brain delivery: In vitro and ex vivo evaluation.

  2021cites this paper
• Progress in nasal drug delivery systems.

  2021cites this paper
• Role of Iron in the Molecular Pathogenesis of Diseases and Therapeutic Opportunities.

  2021cites this paper
• Biodegradable and biocompatible polymeric nanoparticles for enhanced solubility and safe oral delivery of docetaxel: in vivo toxicity evaluation.

  2021cites this paper
• A Dry Powder Platform for Nose-to-Brain Delivery of Dexamethasone: Formulation Development and Nasal Deposition Studies

  2021cites this paper
• Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system.

  2021cites this paper
• Biomaterials for Neural Tissue Engineering

  2021cites this paper
• Liposome Consolidated with Cyclodextrin Provides Prolonged Drug Retention Resulting in Increased Drug Bioavailability in Brain

  2020cites this paper
• Biodegradable hypoxia biomimicry microspheres for bone tissue regeneration

  2020cites this paper
• Relieving ferroptosis may partially reverse neurodegeneration of the auditory cortex

  2020cites this paper
• Deferoxamine deconditioning increases neuronal vulnerability to hemoglobin.

  2020cites this paper
• Nanoparticlized System: Promising Approach for the Management of Alzheimer's Disease through Intranasal Delivery.

  2020cites this paper
• Azacitidine Loaded PLGA Nanoparticles and their Dual Release Mechanism

  2020cites this paper
• Importance of Different Novel Nasal Drug Delivery System-A Review

  2020cites this paper
• The Correlation between Physical Crosslinking and Water-Soluble Drug Release from Chitosan-Based Microparticles

  2020cites this paper
• Bio-inspired apatite particles limit skin penetration of drugs for dermatology applications.

  2020cites this paper
• Investigation of Cytotoxicity and Cell Uptake of Cationic Beta-Cyclodextrins as Valid Tools in Nasal Delivery

  2020cites this paper
• Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

  2020cites this paper
• Recent Advancement of Molecular Structure and Biomaterial Function of Chitosan from Marine Organisms for Pharmaceutical and Nutraceutical Application

  2020cites this paper
• Solubility enhancement and application of cyclodextrins in local drug delivery

  2020cites this paper
• Nose to brain delivery of antiretroviral drugs in the treatment of neuroAIDS

  2020cites this paper
• Nose-to-Brain Delivery of Antioxidants as a Potential Tool for the Therapy of Neurological Diseases

  2020cites this paper
• Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders

  2020cites this paper
• Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum 1 microparticles 2

  2020cites this paper
• Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.

  2019cites this paper
• Strategies to facilitate or block nose-to-brain drug delivery.

  2019cites this paper
• Could spray-dried microbeads with chitosan glutamate be considered as promising vaginal microbicide carriers? The effect of process variables on the in vitro functional and physicochemical characteristics.

  2019cites this paper
• Transnasal delivery of the peptide agonist specific to Neuromedin-U receptor2 to the brain for the treatment of obesity.

  2019cites this paper
• Intranasal Drug Delivery After Intracerebral Hemorrhage

  2019cites this paper
• Solubility enhancement and application of cyclodextrins in local drug delivery

  2019cites this paper
• Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration

  2019cites this paper
• Chitosan coated human serum albumin nanoparticles: A promising strategy for nose-to-brain drug delivery.

  2019cites this paper
• Nose-to-brain delivery of lipid-based nanosystems for epileptic seizures and anxiety crisis

  2019cites this paper
• Spray-dried alginate microparticles for potential intranasal delivery of ropinirole hydrochloride: development, characterization and histopathological evaluation

  2019cites this paper
• Increasing protective activity of genistein by loading into transfersomes: A new potential adjuvant in the oxidative stress-related neurodegenerative diseases?

  2019cites this paper
• Thermo-sensitive keratin hydrogel against iron-induced brain injury after experimental intracerebral hemorrhage.

  2019cites this paper
• An enhanced charge-driven intranasal delivery of nicardipine attenuates brain injury after intracerebral hemorrhage.

  2019cites this paper
• Effect of Cyclodextrin Derivatization on Solubility and Efficacy of Drugs

  2019cites this paper
• Drug delivery and targeting to the brain through nasal route: Mechanisms, Applications and Challenges.

  2019cites this paper
• Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry.

  2019cites this paper
• The Role of Combined Penetration Enhancers in Nasal Microspheres on In Vivo Drug Bioavailability

  2018cites this paper
• Mixed cationic liposomes for brain delivery of drugs by the intranasal route: The acetylcholinesterase reactivator 2-PAM as encapsulated drug model.

  2018cites this paper
• Brain targeting of resveratrol by nasal administration of chitosan‐coated lipid microparticles

  2018cites this paper
• Aqueous injection of quercetin: An approach for confirmation of its direct in vivo cardiovascular effects.

  2018cites this paper
• Recent advances in carrier mediated nose‐to‐brain delivery of pharmaceutics

  2018cites this paper